Section on Immuno-Engineering. National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 50 South Drive, Bethesda MD, 20894, United States.
Acta Biomater. 2021 Oct 1;133:17-33. doi: 10.1016/j.actbio.2021.04.023. Epub 2021 Apr 24.
Research on the foreign body response (FBR) to biomaterial implants has been focused on the roles that the innate immune system has on mediating tolerance or rejection of implants. However, the immune system also involves the adaptive immune response and it must be included in order to form a complete picture of the response to biomaterials and medical implants. In this review, we explore recent understanding about the roles of adaptive immune cells, specifically T cells, in modulating the immune response to biomaterial implants. The immune response to implants elicits a delicate balance between tissue repair and fibrosis that is mainly regulated by three types of T helper cell responses -T helper type 1, T helper type 2, and T helper type 17- and their crosstalk with innate immune cells. Interestingly, many T cell response mechanisms to implants overlap with the process of fibrosis or repair in different tissues. This review explores the fibrotic and regenerative T cell biology and draws parallels to T cell responses to biomaterials. Additionally, we also explore the biomedical engineering advancements in biomaterial applications in designing particle and scaffold systems to modulate T cell activity for therapeutics and devices. Not only do the deliberate engineering design of physical and chemical material properties and the direct genetic modulation of T cells not only offer insights to T cell biology, but they also present different platforms to develop immunomodulatory biomaterials. Thus, an in-depth understanding of T cells' roles can help to navigate the biomaterial-immune interactions and reconsider the long-lasting adaptive immune response to implants, which, in the end, contribute to the design of immunomodulatory medical implants that can advance the next generation of regenerative therapy. STATEMENT OF SIGNIFICANCE: This review article integrates knowledge of adaptive immune responses in tissue damage, wound healing, and medical device implantation. These three fields, often not discussed in conjunction, are important to consider when evaluating and designing biomaterials. Through incorporation of basic biological research alongside engineering research, we provide an important lens through which to evaluate adaptive immune contributions to regenerative medicine and medical device development.
对生物材料植入物的异物反应 (FBR) 的研究一直集中在先天免疫系统在介导植入物的耐受或排斥方面的作用上。然而,免疫系统还涉及适应性免疫反应,为了形成对生物材料和医疗植入物反应的完整图景,必须将其包括在内。在这篇综述中,我们探讨了适应性免疫细胞(特别是 T 细胞)在调节对生物材料植入物的免疫反应中的作用的最新认识。植入物引起的免疫反应在组织修复和纤维化之间产生了微妙的平衡,主要由三种类型的 T 辅助细胞反应——T 辅助细胞 1、T 辅助细胞 2 和 T 辅助细胞 17——及其与先天免疫细胞的相互作用来调节。有趣的是,许多对植入物的 T 细胞反应机制与不同组织中的纤维化或修复过程重叠。本综述探讨了纤维化和再生 T 细胞生物学,并与生物材料的 T 细胞反应进行了比较。此外,我们还探讨了生物医学工程在设计颗粒和支架系统以调节 T 细胞活性用于治疗和设备方面的进展,对生物材料的应用。物理和化学材料特性的故意工程设计以及 T 细胞的直接基因调节不仅为 T 细胞生物学提供了新的见解,而且为开发免疫调节生物材料提供了不同的平台。因此,深入了解 T 细胞的作用有助于引导生物材料-免疫相互作用,并重新考虑对植入物的持久适应性免疫反应,最终有助于设计可促进下一代再生治疗的免疫调节医疗植入物。意义声明:本文综述了组织损伤、伤口愈合和医疗器械植入物中适应性免疫反应的知识。这三个领域通常不结合在一起讨论,在评估和设计生物材料时需要考虑这些领域。通过将基础生物学研究与工程学研究相结合,我们提供了一个重要的视角,可以评估适应性免疫对再生医学和医疗器械发展的贡献。